ABSTRACT
Despite retrospective studies which suggest reduced morbidity in malnourished cancer patients receiving nutrition support, the use of nutrition support in the cancer patient remains controversial. Prospective, randomized trials have, in general, failed to document a significant reduction in complications in cancer patients undergoing therapy and receiving nutrition support.1,2,5,6 Only in severely malnourished patient populations undergoing aggressive anti neoplastic therapy has objective benefit from nutrition support been clearly documented.7,8 Thus, controversy remains regarding the clinical efficacy of nutrition support in the tumor-bearing host.
